Dyselectrolytemias  ||| S:0 E:19 ||| NNP
and  ||| S:19 E:23 ||| CC
arrhythmias  ||| S:23 E:35 ||| JJ
Critical  ||| S:35 E:44 ||| JJ
care  ||| S:44 E:49 ||| NN
patients  ||| S:49 E:58 ||| NNS
are  ||| S:58 E:62 ||| VBP
submitted  ||| S:62 E:72 ||| VBN
to  ||| S:72 E:75 ||| TO
multiple  ||| S:75 E:84 ||| JJ
derangements  ||| S:84 E:97 ||| NN
of  ||| S:97 E:100 ||| IN
vital  ||| S:100 E:106 ||| JJ
parameters ||| S:106 E:116 ||| NNS
.  ||| S:116 E:118 ||| .
Even  ||| S:118 E:123 ||| RB
in  ||| S:123 E:126 ||| IN
patients  ||| S:126 E:135 ||| NNS
with  ||| S:135 E:140 ||| IN
a  ||| S:140 E:142 ||| DT
normally  ||| S:142 E:151 ||| RB
performing  ||| S:151 E:162 ||| VBG
heart ||| S:162 E:167 ||| NN
,  ||| S:167 E:169 ||| ,
its  ||| S:169 E:173 ||| PRP$
electrical  ||| S:173 E:184 ||| JJ
activity  ||| S:184 E:193 ||| NN
can  ||| S:193 E:197 ||| MD
be  ||| S:197 E:200 ||| VB
strongly  ||| S:200 E:209 ||| RB
influenced  ||| S:209 E:220 ||| VBN
by  ||| S:220 E:223 ||| IN
dyselectrolytemias ||| S:223 E:241 ||| NN
,  ||| S:241 E:243 ||| ,
acid-base  ||| S:243 E:253 ||| JJ
imbalance  ||| S:253 E:263 ||| NN
and  ||| S:263 E:267 ||| CC
aggressive  ||| S:267 E:278 ||| JJ
drug  ||| S:278 E:283 ||| NN
therapy ||| S:283 E:290 ||| NN
.  ||| S:290 E:292 ||| .
In  ||| S:292 E:295 ||| IN
this  ||| S:295 E:300 ||| DT
paper ||| S:300 E:305 ||| NN
,  ||| S:305 E:307 ||| ,
the  ||| S:307 E:311 ||| DT
basic  ||| S:311 E:317 ||| JJ
principles  ||| S:317 E:328 ||| NNS
of  ||| S:328 E:331 ||| IN
the  ||| S:331 E:335 ||| DT
electrophysiologic  ||| S:335 E:354 ||| JJ
properties  ||| S:354 E:365 ||| NNS
of  ||| S:365 E:368 ||| IN
the  ||| S:368 E:372 ||| DT
heart  ||| S:372 E:378 ||| NN
are  ||| S:378 E:382 ||| VBP
reviewed ||| S:382 E:390 ||| VBN
,  ||| S:390 E:392 ||| ,
and  ||| S:392 E:396 ||| CC
the  ||| S:396 E:400 ||| DT
impact  ||| S:400 E:407 ||| NN
of  ||| S:407 E:410 ||| IN
dyselectrolytemias  ||| S:410 E:429 ||| NN
on  ||| S:429 E:432 ||| IN
heart  ||| S:432 E:438 ||| NN
excitability  ||| S:438 E:451 ||| NNS
are  ||| S:451 E:455 ||| VBP
underlined ||| S:455 E:465 ||| VBN
.  ||| S:465 E:467 ||| .
Some  ||| S:467 E:472 ||| DT
clinically  ||| S:472 E:483 ||| JJ
relevant  ||| S:483 E:492 ||| JJ
aspects  ||| S:492 E:500 ||| NNS
are  ||| S:500 E:504 ||| VBP
described  ||| S:504 E:514 ||| VBN
in  ||| S:514 E:517 ||| IN
greater  ||| S:517 E:525 ||| JJR
depth ||| S:525 E:530 ||| NN
,  ||| S:530 E:532 ||| ,
with  ||| S:532 E:537 ||| IN
respect  ||| S:537 E:545 ||| NN
to  ||| S:545 E:548 ||| TO
life-threatening  ||| S:548 E:565 ||| JJ
arrhythmias ||| S:565 E:576 ||| NN
.  ||| S:576 E:578 ||| .
